MRNA
MRNA
Select locations
Select company type
Select type
Select industries
Select industry
Number of employees
Min.
Max.
Founding year
Lock keywords
Exclude keywords
Define optional keywords
Messenger RNA (mRNA) is a type of RNA molecule that carries genetic information from DNA to the ribosome, where it is translated into a sequence of amino acids that form proteins.
... Capability for mRNA, circRNA, saRNA, and other types of RNA. Process development including RNA synthesis, purification, and LNP encapsulation. GMP manufacturing scaling from 1g to 50g. ...
... Innoforce - mRNA&CGT ...
... Compound from series X induces mRNA localization to RNA granules resulting in the decrease of mRNA ...
... modulators, preclinical stage in lung fibrosis and applicable across many fibrotic diseases), Oncology (c-Myc mRNA biology modulators and mutation agnostic mKras mRNA biology modulators), and Neuroscience (Tau - Alzheimer's disease and Pain - Nav1.7 mRNA biology modulators). ...
... Our mRNA technology platform that allows our scientists to develop medicines to help prevent or treat disease. ...
... Our mRNA technology platform that allows our scientists to develop medicines to help prevent or treat disease. ...
... – Lynxgen Therapeutics LongSAGE mRNA ...
... Assay Kits – Lynxgen Therapeutics LongSAGE mRNA ...
... , proprietary and complete suite of technology platforms to enable the use of mRNAs as a therapeutic agent: The Stabilized Non-Immunogenic mRNA (SNIM® RNA) platform as well as the complementary technologies for mRNA formulation, stabilization, manufacturing and multi-route delivery. ...
... , non-immunogenic messenger RNA (mRNA) and lipidoid nanoparticle (LNP) technology platforms to discover, design and develop innovative therapies and vaccines. As an mRNA pioneer for more than a decade, our technologies enable the delivery of highly potent mRNA-based drug ...
... mRNA PLATFORM | sapientis ...
... Combined Therapeutics (CTx) has developed a unique modified mRNA platform combining an increased safety profile together with powerful efficacy, to advance the next generation of vaccines accomplished through controlled biodistribution that targets protein expression to specific tissues ...
... Combined Therapeutics (CTx) has developed a unique modified mRNA platform combining an increased safety profile together with powerful efficacy, to advance the next generation of vaccines accomplished through controlled biodistribution that targets protein expression to specific tissues ...
... used as a positive control for mRNA transfections. mRNA length : 1967 bp Concentration: 1mg/ml Buffer: 1 mM sodium citrate, pH 6.5 PureBoost™ technologyCellerna mRNAs are produced via PureBoost™ technology which maximizes protein expression and minimizes mRNA immunogenicity. ...
... Uniform polyadenylation (100 bp polyA-tail) and almost perfect capping (Cap1 > 98%) mimic natural mRNA and ensure efficient translation. Sequence engineering or chemical modification reduces the innate antiviral response to single-stranded mRNA. ...
... Kernal Biologics Announces $25M Series A Financing to Advance its mRNA 2.0 Technology for Oncology | Kernal ...
... Pushing mRNA therapeutics for cancer, Cambridge startup nabs Series A to explore next-gen approach | Kernal ...
... mRNA science at the University of ...